Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05999240
What this trial is testing

Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder

Who this might be right for
Autism Spectrum Disorder
New York State Psychiatric Institute 30
Testing effectiveness (Phase 2)Study completedNCT00175955
What this trial is testing

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Medication-induced
UCB Pharma 70
Not applicableStudy completedNCT04668248
What this trial is testing

Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing

Who this might be right for
Medication Administered in ErrorAntipsychotics and Neuroleptics Toxicity
Brigham and Women's Hospital 47
Post-approval studies (Phase 4)UnknownNCT00395915
What this trial is testing

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Universita di Verona 106
Early research (Phase 1)Study completedNCT00796640
What this trial is testing

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35
Post-approval studies (Phase 4)Study completedNCT00797927
What this trial is testing

Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia

Who this might be right for
Schizophrenia
National Taiwan University Hospital 30
Not applicableStudy completedNCT01029769
What this trial is testing

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Technical University of Munich 350
Not applicableStudy completedNCT02600741
What this trial is testing

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 296
Early research (Phase 1)UnknownNCT06301074
What this trial is testing

The Phase I Study of HS-10509 in Chinese Adult Subjects

Who this might be right for
Schizophrenia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 80
Not applicableStudy completedNCT00474227
What this trial is testing

Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness

Who this might be right for
Obesity
Lev-Hasharon Mental Healtlh Center 50
Not applicableStudy completedNCT02712463
What this trial is testing

Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag Ltd. 310
Testing effectiveness (Phase 2)Ended earlyNCT00439634
What this trial is testing

Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia

Who this might be right for
Schizophrenia
Sanofi 873
Testing effectiveness (Phase 2)Study completedNCT03557931
What this trial is testing

Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Who this might be right for
Schizophrenia
Astellas Pharma Global Development, Inc. 233
Testing effectiveness (Phase 2)Study completedNCT02953639
What this trial is testing

Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

Who this might be right for
Schizophrenia
Hoffmann-La Roche 214
Post-approval studies (Phase 4)Study completedNCT02339844
What this trial is testing

Pan European Collaboration on Antipsychotic Naïve Schizophrenia II

Who this might be right for
Schizophrenia
University of Copenhagen 130
Post-approval studies (Phase 4)Study completedNCT00621998
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-Induced Tardive Dyskinesia
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60
Early research (Phase 1)Study completedNCT01924520
What this trial is testing

Oral Multiple-dose Study in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Astellas Pharma Inc 32
Post-approval studies (Phase 4)Study completedNCT02305823
What this trial is testing

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 203
Not applicableStudy completedNCT02192723
What this trial is testing

Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

Who this might be right for
Schizophrenia
Beijing HuiLongGuan Hospital 550
Large-scale testing (Phase 3)Study completedNCT00065273
What this trial is testing

Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay

Who this might be right for
Mental RetardationDevelopmental Delay Disorder
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation